NovoCure (NVCR) Operating Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,557.00 |
| Dec 31, 2025 | -162.00 |
| Sep 30, 2025 | 334.00 |
| Jun 30, 2025 | -46.00 |
| Mar 31, 2025 | 1,482.00 |
| Dec 31, 2024 | -1,856.00 |
| Sep 30, 2024 | 164.00 |
| Jun 30, 2024 | 764.00 |
| Mar 31, 2024 | 868.00 |
| Dec 31, 2023 | 709.00 |
| Sep 30, 2023 | 396.00 |
| Jun 30, 2023 | -40.00 |
| Mar 31, 2023 | -1,585.00 |
| Dec 31, 2022 | -1,468.00 |
| Sep 30, 2022 | -379.00 |
| Jun 30, 2022 | -1,441.00 |
| Mar 31, 2022 | 1,698.00 |
| Dec 31, 2021 | -1,116.00 |
| Sep 30, 2021 | 281.00 |
| Jun 30, 2021 | -914.00 |
| Mar 31, 2021 | -847.00 |
| Dec 31, 2020 | -292.00 |
| Sep 30, 2020 | 557.00 |
| Jun 30, 2020 | 907.00 |
| Mar 31, 2020 | -347.00 |
| Dec 31, 2019 | -403.00 |
| Sep 30, 2019 | 281.00 |
| Jun 30, 2019 | 972.00 |
| Mar 31, 2019 | 409.00 |
| Dec 31, 2018 | -433.00 |
| Sep 30, 2018 | 342.00 |
| Jun 30, 2018 | 1,280.00 |
| Mar 31, 2018 | -1,592.00 |
| Dec 31, 2017 | 342.00 |
| Sep 30, 2017 | 2,866.00 |
| Jun 30, 2017 | -213.00 |
| Mar 31, 2017 | 2,077.00 |
| Dec 31, 2016 | 7,130.00 |
| Sep 30, 2016 | 7,740.00 |
| Jun 30, 2016 | 3,687.00 |
| Mar 31, 2016 | 248.00 |
| Dec 31, 2015 | 2,356.00 |
| Sep 30, 2015 | 14,508.00 |
| Jun 30, 2015 | 559.00 |
| Mar 31, 2015 | 18,395.00 |
| Dec 31, 2014 | -19,599.00 |